Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$909,168
+$576,212 QoQ
Shares Held
758
+109.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#3,223
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ONE WEALTH CAPITAL MANAGEMENT, LLC holds $4,407,727 across 8 Drug Manufacturers - General names. LLY ranks #1 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
758 | $909,168 | |
| 2 | NVS |
Novartis AG
|
5,238 | $820,899 | |
| 3 | NVO |
Novo Nordisk A S
|
15,365 | $736,598 | |
| 4 | AMGN |
Amgen Inc
|
1,698 | $614,879 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,631 | $595,083 | |
| 6 | ABBV |
AbbVie Inc.
|
1,171 | $294,670 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,960 | $228,175 | |
| 8 | JNJ |
Johnson & Johnson
|
820 | $208,255 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $909,168 | 758 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $332,956 | 362 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,545,389 | 1,438 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,162,812 | 1,524 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,233,995 | 1,583 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,337,974 | 1,620 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $942,612 | 1,221 | Shares | Sole | 2025-01-07 | |
| No filing history on record for this holder in this stock. | ||||||